02616 CSTONE PHARMA-B
- 1.090
- +0.210+23.86%
CSTONE PHARMA-B News
CSTONE PHARMA-B: 2023 ANNUAL REPORT
CSTONE PHARMA-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023
CSTONE PHARMA-B: DATE OF BOARD MEETING
CSTONE PHARMA-B: INTERIM REPORT 2023
CSTONE PHARMA-B: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023
CSTONE PHARMA-B: DATE OF BOARD MEETING
CSTONE PHARMA-B: 2022 ANNUAL REPORT
CSTONE PHARMA-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2022
CSTONE PHARMA-B: DATE OF BOARD MEETING
CSTONE PHARMA-B: POSITIVE PROFIT ALERT
CSTONE PHARMA-B: INTERIM REPORT 2022
CSTONE PHARMA-B: (1) ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2022; (2) CESSATION TO ACT AS THE CHIEF EXECUTIVE OFFICER, THE EXECUTIVE DIRECTOR, THE CHAIRMAN OF THE STRATEGY COMMITTEE AND AN AUTHORIZED REPRESENTATIVE; AND (3) APPOI
CSTONE PHARMA-B: DATE OF BOARD MEETING
CSTONE PHARMA-B: 2021 ANNUAL REPORT
CSTONE PHARMA-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2021 AND RESUMPTION OF TRADING
CSTONE PHARMA-B: DATE OF BOARD MEETING
CSTONE PHARMA-B: INSIDE INFORMATION - (1) DELAY IN PUBLICATION OF ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021; (2) POSTPONEMENT OF BOARD MEETING; AND (3) SUSPENSION OF TRADING
CSTONE PHARMA-B: DATE OF BOARD MEETING
CSTONE PHARMA-B: INTERIM REPORT 2021
CSTONE PHARMA-B: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2021
Analysis
Price Target
No Data
